211 related articles for article (PubMed ID: 30063938)
1. Printing T
Alomari M; Vuddanda PR; Trenfield SJ; Dodoo CC; Velaga S; Basit AW; Gaisford S
Int J Pharm; 2018 Oct; 549(1-2):363-369. PubMed ID: 30063938
[TBL] [Abstract][Full Text] [Related]
2. Personalisation of warfarin therapy using thermal ink-jet printing.
Vuddanda PR; Alomari M; Dodoo CC; Trenfield SJ; Velaga S; Basit AW; Gaisford S
Eur J Pharm Sci; 2018 May; 117():80-87. PubMed ID: 29414676
[TBL] [Abstract][Full Text] [Related]
3. Water-based 3D inkjet printing of an oral pharmaceutical dosage form.
Cader HK; Rance GA; Alexander MR; Gonçalves AD; Roberts CJ; Tuck CJ; Wildman RD
Int J Pharm; 2019 Jun; 564():359-368. PubMed ID: 30978485
[TBL] [Abstract][Full Text] [Related]
4. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
[TBL] [Abstract][Full Text] [Related]
5. Drop-on-demand printing of personalised orodispersible films fabricated by precision micro-dispensing.
Tam CH; Alexander M; Belton P; Qi S
Int J Pharm; 2021 Dec; 610():121279. PubMed ID: 34774697
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different substrates for inkjet printing of rasagiline mesylate.
Genina N; Janßen EM; Breitenbach A; Breitkreutz J; Sandler N
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1075-83. PubMed ID: 23563101
[TBL] [Abstract][Full Text] [Related]
7. Combination L-T3 and L-T4 therapy for hypothyroidism.
Wartofsky L
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):460-6. PubMed ID: 23974776
[TBL] [Abstract][Full Text] [Related]
8. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.
Thabet Y; Lunter D; Breitkreutz J
Int J Pharm; 2018 Jul; 546(1-2):180-187. PubMed ID: 29753906
[TBL] [Abstract][Full Text] [Related]
9. Additive manufacturing of personalized orodispersible warfarin films.
Sjöholm E; Sandler N
Int J Pharm; 2019 Jun; 564():117-123. PubMed ID: 30974195
[TBL] [Abstract][Full Text] [Related]
10. Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing.
Buanz AB; Saunders MH; Basit AW; Gaisford S
Pharm Res; 2011 Oct; 28(10):2386-92. PubMed ID: 21544688
[TBL] [Abstract][Full Text] [Related]
11. Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure.
Planchette C; Pichler H; Wimmer-Teubenbacher M; Gruber M; Gruber-Woelfler H; Mohr S; Tetyczka C; Hsiao WK; Paudel A; Roblegg E; Khinast J
Int J Pharm; 2016 Jul; 509(1-2):518-527. PubMed ID: 26541301
[TBL] [Abstract][Full Text] [Related]
12. Bioidentical thyroid replacement therapy in practice: Delivering a physiologic T4:T3 ratio for improved patient outcomes with the Listecki-Snyder protocol.
Snyder S; Listecki RE
Int J Pharm Compd; 2012; 16(5):376-80. PubMed ID: 23072197
[TBL] [Abstract][Full Text] [Related]
13. Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy.
Yan TT; Lv ZF; Tian P; Lin MM; Lin W; Huang SY; Chen YZ
Drug Dev Ind Pharm; 2020 Apr; 46(4):531-538. PubMed ID: 32141352
[TBL] [Abstract][Full Text] [Related]
14. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
15. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.
Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW
Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of hypothyroidism. T4 or better T3/T4?].
Meng W
MMW Fortschr Med; 2000 Apr; 142(15):39-40. PubMed ID: 10842475
[No Abstract] [Full Text] [Related]
17. Fabricating 3D printed orally disintegrating printlets using selective laser sintering.
Fina F; Madla CM; Goyanes A; Zhang J; Gaisford S; Basit AW
Int J Pharm; 2018 Apr; 541(1-2):101-107. PubMed ID: 29454028
[TBL] [Abstract][Full Text] [Related]
18. Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks.
Trenfield SJ; Xian Tan H; Awad A; Buanz A; Gaisford S; Basit AW; Goyanes A
Int J Pharm; 2019 Aug; 567():118443. PubMed ID: 31212052
[TBL] [Abstract][Full Text] [Related]
19. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat.
Escobar-Morreale HF; del Rey FE; Obregón MJ; de Escobar GM
Endocrinology; 1996 Jun; 137(6):2490-502. PubMed ID: 8641203
[TBL] [Abstract][Full Text] [Related]
20. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
